Fuxing Hospital affiliated to Capital Medical University

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis	Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies	Recruiting	Not applicable	2025-04-24		NCT06699394

Clinical trials